NO20053677L - Fremgangsmate for fremstilling av albumin - Google Patents

Fremgangsmate for fremstilling av albumin

Info

Publication number
NO20053677L
NO20053677L NO20053677A NO20053677A NO20053677L NO 20053677 L NO20053677 L NO 20053677L NO 20053677 A NO20053677 A NO 20053677A NO 20053677 A NO20053677 A NO 20053677A NO 20053677 L NO20053677 L NO 20053677L
Authority
NO
Norway
Prior art keywords
stabilizer
optionally
albumin
albumin solution
groups
Prior art date
Application number
NO20053677A
Other languages
English (en)
Norwegian (no)
Other versions
NO20053677D0 (no
Inventor
Werner Gehringer
Katharina Pock
Tor-Einar Svae
Christoph Kannicht
Juergen Romisch
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Publication of NO20053677D0 publication Critical patent/NO20053677D0/no
Publication of NO20053677L publication Critical patent/NO20053677L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38Albumins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO20053677A 2003-02-13 2005-07-29 Fremgangsmate for fremstilling av albumin NO20053677L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT2182003 2003-02-13
PCT/EP2004/001397 WO2004071524A1 (de) 2003-02-13 2004-02-13 Albuminlösung und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
NO20053677D0 NO20053677D0 (no) 2005-07-29
NO20053677L true NO20053677L (no) 2005-10-31

Family

ID=32854882

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053677A NO20053677L (no) 2003-02-13 2005-07-29 Fremgangsmate for fremstilling av albumin

Country Status (22)

Country Link
EP (1) EP1592439B1 (sr)
JP (1) JP2006517938A (sr)
KR (1) KR20050103292A (sr)
CN (1) CN100384471C (sr)
AT (1) ATE362376T1 (sr)
AU (1) AU2004212324B2 (sr)
BR (1) BRPI0407458A (sr)
CA (1) CA2514163A1 (sr)
CY (1) CY1106793T1 (sr)
DE (1) DE502004003834D1 (sr)
DK (1) DK1592439T3 (sr)
ES (1) ES2285427T3 (sr)
IL (1) IL169828A0 (sr)
MX (1) MXPA05008276A (sr)
NO (1) NO20053677L (sr)
PL (1) PL376644A1 (sr)
PT (1) PT1592439E (sr)
RS (1) RS50891B (sr)
RU (1) RU2305556C2 (sr)
UA (1) UA80469C2 (sr)
WO (1) WO2004071524A1 (sr)
ZA (1) ZA200506452B (sr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005023155A1 (de) * 2005-05-13 2006-11-16 Albutec Gmbh Albuminlösung
AU2006334795B2 (en) * 2005-12-22 2012-02-16 Csl Behring Gmbh Octanoate-reduced human albumin
ES2332846B1 (es) 2007-10-26 2010-07-08 Grifols, S.A. Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos.
ES2294976B1 (es) 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
EP2382993A1 (en) 2010-04-19 2011-11-02 KTB Tumorforschungsgesellschaft mbH Combination of drugs with protein-binding prodrugs
CN111195351A (zh) * 2020-01-20 2020-05-26 华兰生物工程重庆有限公司 5%低浓度人血白蛋白的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
US5250662A (en) * 1989-10-05 1993-10-05 Alpha Therapeutic Corporation Albumin purification
DE19729778A1 (de) * 1997-07-11 1999-01-21 Blutspendedienst Der Drk Lande Verfahren zur Herstellung von virusinaktivierten biologischen Flüssigkeiten
US5919907A (en) * 1997-12-22 1999-07-06 Shanbrom Technologies Llc Preparation and utilization of a novel sterile albumin
IL136552A (en) * 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration

Also Published As

Publication number Publication date
RS50891B (sr) 2010-08-31
DE502004003834D1 (de) 2007-06-28
MXPA05008276A (es) 2006-03-21
PL376644A1 (pl) 2006-01-09
ZA200506452B (en) 2007-01-31
RU2305556C2 (ru) 2007-09-10
WO2004071524A1 (de) 2004-08-26
AU2004212324B2 (en) 2009-05-07
EP1592439B1 (de) 2007-05-16
CY1106793T1 (el) 2012-05-23
ES2285427T3 (es) 2007-11-16
AU2004212324A1 (en) 2004-08-26
UA80469C2 (en) 2007-09-25
PT1592439E (pt) 2007-06-22
ATE362376T1 (de) 2007-06-15
RU2005128507A (ru) 2006-01-20
CN1798573A (zh) 2006-07-05
NO20053677D0 (no) 2005-07-29
KR20050103292A (ko) 2005-10-28
DK1592439T3 (da) 2007-09-10
CA2514163A1 (en) 2004-08-26
BRPI0407458A (pt) 2006-01-31
EP1592439A1 (de) 2005-11-09
RS20050624A (en) 2007-06-04
CN100384471C (zh) 2008-04-30
JP2006517938A (ja) 2006-08-03
IL169828A0 (en) 2011-08-01

Similar Documents

Publication Publication Date Title
EP0530173B1 (de) Verfahren zur Inaktivierung von Prionen
NO20053677L (no) Fremgangsmate for fremstilling av albumin
CN105392795B (zh) 生产肉毒杆菌毒素的方法
CN102952187B (zh) 一种高纯度牛血清白蛋白的制备方法
CN105886583A (zh) 一种牛骨髓肽提取方法
BRPI0401650A (pt) Extração rápida de rna de células e tecidos
CN105876442A (zh) 一种羊骨髓肽提取方法
BRPI0519406A2 (pt) manoproteÍna com solubilidade integral em vinho e sua aplicaÇço na estabilizaÇço de vinho
JP2017521451A (ja) 微細藻類バイオマスから可溶性タンパク質を抽出するための方法
BRPI0412835A (pt) processo para preparação de uma solução de alfa-1-antitripsina
ATE226613T1 (de) Verfahren zur extraktion von lycopin
BR0313045A (pt) Processo para melhorar o rendimento da produção de proteìna recombinante de plantas
CN103695513A (zh) 一种提高低分子量大豆肽产量的方法
CN106086132A (zh) 一种利用银杏果皮制备抗氧化肽的方法
Altuner A predictive modelling study for using high hydrostatic pressure, a food processing technology, for protein extraction
BR112023004624A2 (pt) Processo para preparar um produto à base de plantas fermentado contendo proteína
ATE221323T1 (de) Verfahren zur herstellung eines eiweissisolats aus einer eiweisshaltigen substanz
WO2021260041A3 (en) Method for separation of potato proteins with reduced enzymatic activity from potato fruit juice
SE0100801L (sv) Metod för förbehandling av mjölk vid mikrofiltrering
CN1844156A (zh) 真菌多糖精化提纯工艺
Islam et al. Enzyme processing of soy flour with minimized protein loss
US4894444A (en) Recovery and purification of immunogens from immunogen-alum complexes
US2432970A (en) Method of reducing the pyrogen contents of parenteral solutions
CN106883307A (zh) 一种灰树花水提多糖和碱提多糖分离纯化的方法
Gusarov et al. Systematic Approach to Production Technology Development for Therapeutic Proteins (Using Insulin–Glargine as an Example)

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application